Stelios Papadopoulos

Affiliations

  • Director at Exelixis Inc. (EXEL), 2024-06-05
  • at Regulus Therapeutics Inc. (RGLS), 2024-05-21
  • Director at Biogen Inc. (BIIB), 2022-06-17
  • Large Shareholder, Director at Eucrates Biomedical Acquisition Corp. (EUCR), 2020-11-27
  • Director at Bg Medicine Inc. (BGMD), 2015-11-20
  • Director at Anadys Pharmaceuticals Inc (ANDS), 2011-05-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RGLS $1.08 370,370 Director 1,189,872 2019-05-07 Filing
RGLS $1.09 50,000 Director 835,073 2018-12-28 Filing
RGLS $1.04 26,401 Director 785,073 2018-12-27 Filing
RGLS $0.95 90,000 Director 758,672 2018-12-26 Filing
RGLS $1.38 300,000 Director 668,672 2018-11-16 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EXEL $21.00 11,437 Director 1,260,578 2024-05-20 Filing
EXEL $19.56 84,515 Director 1,220,036 2022-02-22 Filing
EXEL $25.01 5,473 Director 1,288,127 2021-05-11 Filing
EXEL $25.00 5,075 Director 1,253,600 2021-05-11 Filing
EXEL $24.95 10,222 Director 1,218,675 2021-05-11 Filing